Ampicillin - Therapeutic use
Research News and Information

Tuesday, November 24, 2009

Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient.

2 Sep 2009 The magnitude of antigen-specific CD8+ T cell responses is not fixed but correlates with the severity of infection. Although by definition T cell response size is the product of both the capacity to recruit naïve T cells (clonal selection) and their ... Read more...

Leuconostoc spp sepsis in an extremely low birth weight infant: a case report and review of the literature.

30 Aug 2009 A three week old extremely low birth weight (ELBW) infant infected by vancomycin-resistant Leuconostoc spp is presented. Treatment with appropriate antibiotics was successful after the percutaneous inserted central catheter (PICC) was removed. The ... Read more...

Intrapartum antibiotics for known maternal Group B streptococcal colonization.

6 Jul 2009 BACKGROUND: Maternal colonization with group B streptococcus (GBS) during pregnancy increases the risk of neonatal infection by vertical transmission. Administration of intrapartum antibiotic prophylaxis (IAP) during labor has been associated with a ... Read more...

Latest indexed articles for 'Ampicillin - Therapeutic use'

These are the very latest articles for this heading:

• Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient. 2 Sep 2009
• Leuconostoc spp sepsis in an extremely low birth weight infant: a case report and review of the literature. 30 Aug 2009
• Intrapartum antibiotics for known maternal Group B streptococcal colonization. 6 Jul 2009
• Infective endocarditis caused by Streptococcus agalactiae in a native aortic valve, complicated by meningitis and cerebral embolism. 13 Jun 2009
• [Cost of therapeutic failure of ampicillin plus amikacin in the treatment of early neonatal sepsis] 25 May 2009
• Escherichia coli--infected cephalohematoma in an infant. 4 May 2009
• Bacteremia, vertebral diskitis, and osteomyelitis in a man with cirrhosis. 29 Apr 2009
• Acute pyelonephritis: clinical characteristics and the role of the surgical treatment. 18 Apr 2009
• Bacterial complications during pandemic influenza infection. 30 Mar 2009
• New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. 27 Feb 2009
• Neonatal suppurative submandibular sialadenitis. 27 Feb 2009
• Community-acquired Capnocytophaga canimorsus meningitis in adults: report of one case with a subacute course and deafness, and literature review. Feb 2009
• Cervical necrotizing fasciitis. 30 Jan 2009
• Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. 30 Jan 2009
• [Clinical efficacy of ampicillin in treatment of acute odontogenic abscess] 30 Jan 2009
• [Community-acquired Pseudomonas stutzeri meningitis in an immunocompetent patient] 30 Dec 2008
• Retinal vasculitis associated with asymptomatic Gardnerella vaginalis infection: a new clinical entity. 30 Dec 2008
• Association between antimicrobial consumption and resistance in Escherichia coli. 20 Dec 2008
• Changing trend in antimicrobial resistance of pediatric uropathogens in Taiwan. 29 Nov 2008
• Intratonsillar abscess. 29 Nov 2008

See a longer list of these articles.

Technical information about 'Ampicillin'

Definition: Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.

Chemical name: 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-

Registry Number: 69-53-4

Descriptor UI: D000667

Alternative terms: Ampicillin; Aminobenzylpenicillin; Penicillin, Aminobenzyl; Aminobenzyl Penicillin; Ampicillin Sodium; Sodium, Ampicillin; Ampicillin Trihydrate; Trihydrate, Ampicillin; Ukapen; Omnipen; Pentrexyl; Polycillin; Amcill; KS-R1; KS R1; KSR1;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Anti-Bacterial Agents;

Tree Number: D02.065.589.099.750.750.050; D02.886.108.750.750.050; D03.438.260.825.750.050; D03.605.084.737.750.050; D04.075.080.875.099.221.750.750.050;

History Note: 65(64)